Reciprocal hybrids of Atlantic salmon (Salmo salar) x brown trout (S. trutta) confirm a heterotic response to experimentally induced amoebic gill disease (AGD)

Amoebic gill disease (AGD) affects global marine aquaculture production of Atlantic salmon, requiring costly reiterative treatment and negatively impacting fish performance and welfare. Although there has been gradual and ongoing progress in genetic selection to improve host resistance to the causative agent (Neoparamoeba perurans) there has been little focus on the response of interspecific hybrids to AGD challenge. Previous research has demonstrated that Atlantic salmon x brown trout hybrids had reduced requirement for freshwater bathing (based on gross gill signs) during chronic natural AGD exposure, yet there has been no histological or molecular evidence confirming differential host response or parasite abundance. In this study we exposed Atlantic salmon (SS), brown trout (TT) and their reciprocal interspecific hybrids (TS and ST) to a single laboratory challenge (∼700 amoebae.l⁻¹ for 18 days) and compared the resultant infection and disease signs characteristic of AGD. Gill score was significantly higher in SS than in TT and hybrids. Copy number quantification of amoebae on gills was higher in salmon than in hybrids or trout but did not differ between hybrids and trout. Gill histopathology confirmed both an increased amoebae abundance and higher expression of host tissue reaction in SS with significantly higher percentages of lesions harboring hyperplastic lesions. Mid-parent and best-parent heterosis of resistance to N. perurans and host response (gill lesions) was confirmed but did not differ between hybrid crosses. Although limited to a single laboratory infection event, our results support previously reported observations (from natural infection/reinfection) of reduced AGD signs in trout and interspecies hybrids. We conclude that interspecies hybrids have potential to improve our understanding of salmonid resistance to amoebic branchitis and support future gene-based research toward fish disease management.